Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Electrical resistivity imaging of an enhanced aquifer recharge site.
Fields J Jr, Tandy T, Halihan T, Ross R, Beak D, Neill R, Groves J. Fields J Jr, et al. Among authors: tandy t. J Geophys Eng. 2022 Oct;19(5):1095-1110. doi: 10.1093/jge/gxac073. Epub 2022 Oct 6. J Geophys Eng. 2022. PMID: 36778603 Free PMC article.
Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial.
Johnston KC, Bruno A, Pauls Q, Hall CE, Barrett KM, Barsan W, Fansler A, Van de Bruinhorst K, Janis S, Durkalski-Mauldin VL; Neurological Emergencies Treatment Trials Network and the SHINE Trial Investigators. Johnston KC, et al. JAMA. 2019 Jul 23;322(4):326-335. doi: 10.1001/jama.2019.9346. JAMA. 2019. PMID: 31334795 Free PMC article. Clinical Trial.
Randomized phase 2 trial of NP001-a novel immune regulator: Safety and early efficacy in ALS.
Miller RG, Block G, Katz JS, Barohn RJ, Gopalakrishnan V, Cudkowicz M, Zhang JR, McGrath MS, Ludington E, Appel SH, Azhir A; Phase 2 Trial NP001 Investigators. Miller RG, et al. Neurol Neuroimmunol Neuroinflamm. 2015 Apr 9;2(3):e100. doi: 10.1212/NXI.0000000000000100. eCollection 2015 Jun. Neurol Neuroimmunol Neuroinflamm. 2015. PMID: 25884010 Free PMC article.
Patients prone to recurrence after endovascular treatment: periprocedural results of the PRET randomized trial on large and recurrent aneurysms.
Raymond J, Klink R, Chagnon M, Barnwell SL, Evans AJ, Mocco J, Hoh BL, Turk AS, Turner RD, Desal H, Fiorella D, Bracard S, Weill A, Guilbert F, Roy D; PRET Collaborative Group. Raymond J, et al. AJNR Am J Neuroradiol. 2014 Sep;35(9):1667-76. doi: 10.3174/ajnr.A4035. Epub 2014 Jun 19. AJNR Am J Neuroradiol. 2014. PMID: 24948508 Free PMC article. Clinical Trial.
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
Wellens' syndrome.
Tandy TK, Bottomy DP, Lewis JG. Tandy TK, et al. Ann Emerg Med. 1999 Mar;33(3):347-51. doi: 10.1016/s0196-0644(99)70373-2. Ann Emerg Med. 1999. PMID: 10036351 Review.
12 results